Nurx Overview
- Founded
-
2014

- Status
-
Acquired/Merged
- Employees
-
235

- Latest Deal Type
-
M&A
Nurx General Information
Description
Operator of a medication prescription and delivery platform intended to put women in control of their own health. The company's platform allows users to request medications such as birth control, sexual health, and more complex conditions including migraine care and dermatology as well as get delivery without the need to visit a doctor, or hospital, or consult any medical professional, enabling women to have convenient, affordable, and personalized care powered by provider specialization and proprietary technology.
Contact Information
Website
www.nurx.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Healthcare Technology Systems
Clinics/Outpatient Services
Parent Company
Primary Office
- 548 Market Street
- Suite 94061
- San Francisco, CA 94104-5401
- United States
+1 (800) 000-0000
Nurx Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
10. Merger/Acquisition | 01-Feb-2022 | 00000 | Completed | Generating Revenue | ||
9. Debt - General | 31-Dec-2020 | 0000 | 00000 | Completed | Generating Revenue | |
8. Later Stage VC (Series C) | 11-Aug-2020 | 0000 | 00000 | 00000 | Completed | Generating Revenue |
7. Mezzanine | 05-Nov-2019 | 0000 | 00000 | Completed | Generating Revenue | |
6. Later Stage VC | 09-Aug-2019 | 000.00 | 00000 | Completed | Generating Revenue | |
5. Later Stage VC (Series C) | 30-May-2019 | 0000 | 000.00 | 00000 | Completed | Generating Revenue |
4. Early Stage VC (Series B) | 06-Dec-2017 | 000.00 | 000.00 | 00000 | Completed | Generating Revenue |
3. Early Stage VC (Series A) | 01-Nov-2016 | 00.00 | 00.000 | 000.00 | Completed | Generating Revenue |
2. Accelerator/Incubator | 22-Mar-2016 | $120K | $120K | 00.000 | Completed | Startup |
1. Angel (individual) | 15-Sep-2015 | Completed | Startup |
Nurx Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C-1 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
Series C | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
Series B2 | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
Series B1 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
Series A-4 | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.00 | |
Series A-3 | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.00 | |
Series A-2 | 745,944 | $0.000010 | $0.37 | $0.37 | 1x | $0.37 | 1.69% | |
Series A-1 | 4,081,144 | $0.000010 | $1.18 | $1.18 | 1x | $1.18 | 9.27% |
Nurx Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Operator of a medication prescription and delivery platform intended to put women in control of their own health. The co
Other Pharmaceuticals and Biotechnology
San Francisco, CA
235
As of 2022
00000
000000&0
00000
Nurx Competitors (13)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Ro | Venture Capital-Backed | New York, NY | 000 | 00.000 | 00000000000 | 00.000 |
0000 | Venture Capital-Backed | Pacific Palisades, CA | 000 | 00000 | 00000000000 | 00000 |
00000 000000 | Venture Capital-Backed | Toronto, Canada | 00 | 000.00 | 0000000000 0 | 000.00 |
0000000000 | Formerly VC-backed | Oakland, CA | 00 | 00.000 | 000000&0 | 00.000 |
00000 | Venture Capital-Backed | New York, NY | 000 | 00000 | 00000000000 | 00000 |
Nurx Executive Team (12)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Edvard Engesaeth MD | Co-Founder, Innovation Officer & Board Member |
Nurx Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
Andrew Weissman JD | Union Square Ventures | Board Member | 000 0000 |
Chelsea Clinton Ph.D | Clinton Foundation | Board Member | 000 0000 |
Edvard Engesaeth MD | Nurx | Co-Founder, Innovation Officer & Board Member | 000 0000 |
Noah Knauf | Kleiner Perkins | Board Member | 000 0000 |
Regina Benjamin | Self | Board Member | 000 0000 |
Nurx Signals
Nurx Former Investors (33)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Alumni Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
CSC UpShot Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Clinton Foundation | Impact Investing | Minority | 000 0000 | 000000 0 | |
Comcast Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
Dan Knox | Angel (individual) | Minority | 000 0000 | 000000 0 |